The study, published Sept. 29 in the journal Blood Advances, analyzed health records of 5,300 patients with multiple myeloma — 15 percent of which had also been diagnosed with diabetes.
“What we did not expect to see here was that diabetes was actually associated with worse survival outcomes among white individuals with myeloma, but not Black individuals,” Urvi Shah, MD, multiple myeloma specialist at Memorial Sloan Kettering Cancer Center in New York City, told U.S. News in an Oct. 2 report.
Study authors claim this is the first study of its kind to evaluate patient outcomes by race as it relates to multiple myeloma and diabetes.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
